Will CAR file an 8-K disclosing a covenant waiver or material amendment to its corporate credit facilities or vehicle ABS facilities by December 31, 2026?

Base rate is the dominant factor: zero covenant waivers across 2023-2025 through three consecutive guide misses and materially elevated operational stress demonstrates that CAR's corporate and ABS structures have real headroom. The July 2025 $1.1B term loan extension on flat/near-flat terms is a strong contrary indicator to imminent waiver risk — lenders do not extend $1.1B to a covenant-breach candidate. Combined liquidity of ~$2.9B covers base-case plus moderate stress scenarios; only the Stress Scanner 10% Manheim decline scenario (estimated $1.5-2B equity call) meaningfully exceeds liquidity, and that is a tail rather than base case. The 8.5-month window is material but most of the compounding cascade paths (Q1 miss -> Manheim drop -> Pentwater unwind -> ABS spread widening) would need to play out fully before a waiver becomes operationally necessary.

The probability needs to integrate Black Swan C4 (ABS cross-default compound, 5-10% probability, near-EXISTENTIAL) and C1 (One Bad Print Cascade, 20-40% probability) weighted by their conditional probability of forcing a waiver. C4 would force immediate waiver filing ~100% conditional on trigger, contributing ~5-10pp. C1 only partially maps to waiver — most cascade paths resolve via continued fleet equity injection rather than amendment — so conditional probability of waiver given cascade is perhaps 20-30%, contributing 4-12pp. The unresolved voluntary-vs-forced debate on $1B fleet contributions materially widens uncertainty: if contributions were forced by ABS OC pressure, the equity injection runway is shorter than it appears. I weight this slightly above the base rate given compound tail scenarios aggregate to 10-20% before diversification.

The committee explicitly calls the absence of covenant waivers a 'load-bearing positive signal' which is telling — if the committee, which is actively looking for structural red flags, treats this as load-bearing rather than marginal, the base case signals genuine headroom. The Hertz analog is instructive: Hertz eventually did file amendments, but it took multiple years of compounding pressure before amendments were operationally necessary, and CAR is currently at year 1-2 of its pattern. Management's $1B EBITDA floor rhetoric vs FY26 $850M midpoint leaves meaningful buffer to any realistic financial maintenance covenant trip level. Pentwater's 10%+ accumulation at $110-130 signals sophisticated capital views the ABS structure as durable — a forced-seller scenario (a known precursor to covenant stress) is not currently in motion.

Investment-grade corporate waivers are rare events and vehicle ABS structures are specifically designed for residual volatility with built-in equity contribution mechanisms before covenant trips. CAR has been using those mechanisms (over $1B YTD Q3 2025) without triggering waivers, which is the entire point — the structures absorb stress through operational means. The 8.5-month window captures meaningful cascade risk but not enough time for a full compounding pattern to force amendment absent a sharp external shock. The base rate plus structural design bias should anchor the estimate low; the tail scenarios from Black Swan C4 and C1 add meaningful but bounded upside risk.

This is a rare-event forecast so I should resist anchoring too aggressively toward the base rate. The specific elevated-risk factors vs a normal year include: a fourth consecutive guide miss now plausible into FY26, management credibility erosion with lenders, Manheim residual volatility entering its Q2-Q4 danger zone, and ABS market spreads being sensitive to rating action. If the committee were pricing STRAINED correctly as E1/E2, the unconditional probability of any material covenant action within 8.5 months in a stressed-but-non-distressed name is historically in the 10-20% range. I settle near the top of base-rate stress given the specific resolution criteria is broad — it includes amendments that loosen tests (not just waivers) and forbearance agreements on any facility, which meaningfully widens the strike.

The cleanest way to reason about this is: which specific path gets us to a waiver in 8.5 months? Path 1 requires Manheim >10% decline cascading into ABS OC rebuild beyond liquidity — that is explicitly the STRAINED-to-CRITICAL threshold, a tail scenario not the base case. Path 2 requires ABS cross-default triggers — Black Swan assigns 5-10%. Path 3 requires rating downgrade to trigger grid pricing/covenant tightening — materially slower than the 8.5-month window. Path 4 requires Pentwater unwind forcing cascade — no current signal. Summing the independent path probabilities with modest correlation adjustment produces a 12-15% range.

Zero waivers across 2023-2025 despite significant stress is the strongest anchor. July 2025 term loan extension at flat terms validates lender trust. Combined $2.9B liquidity adequate for base case. Tail scenarios exist but are explicitly tail — 10% Manheim decline and ABS cross-default are both low-probability triggers. Base rate for investment-grade corporate waivers is low.

Base rate is low but 8.5-month window captures multiple potential catalyst events: Q1 and Q2 prints, full Manheim cycle, and potential rating action. Black Swan C4 at 5-10% plus partial contribution from C1 cascade pushes above pure base rate. Broad resolution criteria (covers any facility amendment loosening terms) widens the strike zone.

The committee calls absence of waivers 'load-bearing positive' — this explicit language suggests real structural headroom, not marginal. ABS structures absorb stress through equity injection mechanisms, which CAR is actively using without triggering amendments. Management $1B EBITDA floor rhetoric leaves buffer above realistic covenant trip. Lean below 15%.